Is VMD.TO undervalued or overvalued?
As of 2025-04-18, the Intrinsic Value of Viemed Healthcare Inc (VMD.TO) is 11.35 CAD. This VMD.TO valuation is based on the model Discounted Cash Flows (Growth Exit 5Y). With the current market price of 10.45 CAD, the upside of Viemed Healthcare Inc is 8.60%. This means that VMD.TO is undervalued by 8.60%.
The range of the Intrinsic Value is 7.62 - 22.83 CAD
| Range | Selected | Upside | |
| a | |||
| DCF (Growth 5y) | 7.62 - 22.83 | 11.35 | 8.6% |
| DCF (Growth 10y) | 15.99 - 47.96 | 23.86 | 128.3% |
| DCF (EBITDA 5y) | 14.21 - 19.31 | 17.22 | 64.8% |
| DCF (EBITDA 10y) | 20.78 - 30.36 | 25.90 | 147.9% |
| Fair Value | 8.29 - 8.29 | 8.29 | -20.62% |
| P/E | 2.96 - 4.69 | 3.95 | -62.2% |
| EV/EBITDA | 8.26 - 11.24 | 9.99 | -4.4% |
| EPV | 1.88 - 2.57 | 2.22 | -78.8% |
| DDM - Stable | 3.25 - 12.88 | 8.07 | -22.8% |
| DDM - Multi | 11.53 - 35.72 | 17.46 | 67.1% |
| Market Cap (mil) | 402.21 |
| Beta | 0.46 |
| Outstanding shares (mil) | 38.49 |
| Enterprise Value (mil) | 402.63 |
| Market risk premium | 5.50% |
| Cost of Equity | 8.56% |
| Cost of Debt | 4.56% |
| WACC | 8.55% |